Tandon R et al (2013) Definition and description of schizophrenia in the DSM-5. Schizophr Res 150(1):3–10

Article  PubMed  Google Scholar 

Maric NP et al (2016) Improving current treatments for Schizophrenia. Drug Dev Res 77(7):357–367

Article  PubMed  CAS  Google Scholar 

Jauhar S, Johnstone M, McKenna PJ (2022) Schizophrenia Lancet 399(10323):473–486

Article  PubMed  CAS  Google Scholar 

Zhu MH et al (2022) Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial. Mil Med Res 9(1):59

PubMed  PubMed Central  CAS  Google Scholar 

Lieberman JA, Small SA, Girgis RR (2019) Early detection and preventive intervention in Schizophrenia: from Fantasy to reality. Am J Psychiatry 176(10):794–810

Article  PubMed  Google Scholar 

Penttilä M et al (2014) Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 205(2):88–94

Article  PubMed  Google Scholar 

Sun SX et al (2007) Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Curr Med Res Opin 23(10):2305–2312

Article  PubMed  Google Scholar 

Brown S et al (2010) Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 196(2):116–121

Article  PubMed  PubMed Central  Google Scholar 

Luo G et al (2023) Gender differences and clinical correlates in the age of the first hospitalization in patients with drug-naïve schizophrenia in China: a cross-sectional study. Eur Arch Psychiatry Clin Neurosci

Goldstein JM (1988) Gender differences in the course of schizophrenia. Am J Psychiatry 145(6):684–689

Article  PubMed  CAS  Google Scholar 

Samara MT et al (2019) How many patients with Schizophrenia do not respond to antipsychotic drugs in the short term? An analysis based on individual Patient Data from Randomized controlled trials. Schizophr Bull 45(3):639–646

Article  PubMed  Google Scholar 

Hambrecht M, Maurer K, Häfner H (1992) Gender differences in schizophrenia in three cultures. Results of the WHO collaborative study on psychiatric disability. Soc Psychiatry Psychiatr Epidemiol 27(3):117–121

Article  PubMed  CAS  Google Scholar 

Harrison G (1990) Searching for the causes of schizophrenia: the role of migrant studies. Schizophr Bull 16(4):663–671

Article  PubMed  CAS  Google Scholar 

Stone WS et al (2020) Association between the duration of untreated psychosis and selective cognitive performance in Community-Dwelling individuals with chronic untreated Schizophrenia in Rural China. JAMA Psychiatry 77(11):1116–1126

Article  PubMed  Google Scholar 

Yu M et al (2023) Correlation between duration of untreated psychosis and long-term prognosis in chronic schizophrenia. Front Psychiatry 14:1112657

Article  PubMed  PubMed Central  Google Scholar 

Deng F et al (2021) Comparison of social cognition using an adapted Chinese version of the reading the mind in the eyes test in drug-naive and regularly medicated individuals with chronic schizophrenia and healthy controls in rural China. Psychol Med 16:1–13 https://doi.org/10.1017/S003329172100043X

Zhang K et al (2024) The impact of prolonged duration of untreated illness on clinical correlates in Chronic Schizophrenia: exploring the relationship with suicide risk. Psychiatry Investig 21(4):422–432

Article  PubMed  PubMed Central  CAS  Google Scholar 

Luo G et al (2024) The relationship between serum prolactin levels and cognitive function in drug-naïve schizophrenia patients: a cross-sectional study. J Neural Transm (Vienna) 131(4):385–391

Article  PubMed  CAS  Google Scholar 

Fišar Z (2023) Biological hypotheses, risk factors, and biomarkers of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 120:110626

Article  PubMed  Google Scholar 

Lee JJ et al (2023) Gut and oral microbiome modulate molecular and clinical markers of schizophrenia-related symptoms: a transdiagnostic, multilevel pilot study. Psychiatry Res 326:115279

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dell’osso B, Altamura AC (2010) Duration of untreated psychosis and duration of untreated illness: new vistas. CNS Spectr 15(4):238–246

Article  PubMed  Google Scholar 

Nkire N et al (2021) Systematic comparison of duration of untreated illness versus duration of untreated psychosis in relation to psychopathology and dysfunction in the Cavan-Monaghan first episode psychosis study (CAMFEPS). Eur Neuropsychopharmacol 47:20–30

Article  PubMed  CAS  Google Scholar 

Heitz U et al (2019) Gender differences in first self-perceived signs and symptoms in patients with an at-risk mental state and first-episode psychosis. Early Interv Psychiatry 13(3):582–588

Article  PubMed  Google Scholar 

Pan XF, Wang L, Pan A (2021) Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol 9(6):373–392

Article  PubMed  Google Scholar 

Beainy C et al (2023) Decreased insight, but not self-stigma or belief about medicine, is associated with greater severity of delusions in a sample of long-stay patients with schizophrenia: a cross-sectional study. BMC Psychiatry 23(1):222

Article  PubMed  PubMed Central  Google Scholar 

de Beurs DP et al (2015) Longitudinal measurement invariance of the Beck scale for suicide ideation. Psychiatry Res 225(3):368–373

Article  PubMed  Google Scholar 

Cha M et al (2023) Concordance between the Columbia-suicide severity rating scale and Beck Scale for suicide ideation in assessing suicide behaviour in young adults with schizophrenia spectrum disorders. Psychiatry Res 319:114965

Article  PubMed  Google Scholar 

Posner K et al (2011) The Columbia-suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 168(12):1266–1277

Article  PubMed  PubMed Central  Google Scholar 

Morin CM et al (2011) The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 34(5):601–608

Article  PubMed  PubMed Central  Google Scholar 

Chung KF, Kan KK, Yeung WF (2011) Assessing insomnia in adolescents: comparison of Insomnia Severity Index, Athens Insomnia Scale and Sleep Quality Index. Sleep Med 12(5):463–470

Article  PubMed  Google Scholar 

Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276

Article  PubMed  CAS  Google Scholar 

Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86(2):420–428

Article  PubMed  CAS  Google Scholar 

Randolph C et al (1998) The repeatable battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 20(3):310–319

Article  PubMed  CAS  Google Scholar 

Zhang BH et al (2015) Gender differences in cognitive deficits in schizophrenia with and without diabetes. Compr Psychiatry 63:1–9

Article  PubMed  CAS  Google Scholar 

Coccaro EF (2020) The overt aggression scale modified (OAS-M) for clinical trials targeting impulsive aggression and intermittent explosive disorder: validity, reliability, and correlates. J Psychiatr Res 124:50–57